R&F Capital Advisors LP - IDERA PHARMACEUTICALS INC ownership

IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K306. A total of 83 filers reported holding IDERA PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 3.86 and the average weighting 0.0%.

Quarter-by-quarter ownership
R&F Capital Advisors LP ownership history of IDERA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$49,000
+40.0%
19,666
-15.6%
0.01%
+8.3%
Q4 2016$35,00023,2910.01%
Other shareholders
IDERA PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Broadfin Capital, LLC 3,094,745$9,563,0000.59%
WALL STREET ASSOCIATES 400,000$1,236,0000.35%
Palo Alto Investors LP 1,257,748$3,886,0000.22%
Baker Brothers Advisors 6,983,107$21,578,0000.18%
NATIXIS 3,148,916$9,730,0000.16%
GUARDIAN LIFE INSURANCE CO OF AMERICA 371,759$1,149,0000.12%
MYCIO WEALTH PARTNERS, LLC 200,000$618,0000.11%
HOLLENCREST CAPITAL MANAGEMENT 177,570$549,0000.10%
DRIEHAUS CAPITAL MANAGEMENT LLC 701,815$2,169,0000.07%
CARL DOMINO INC 29,137$90,0000.07%
View complete list of IDERA PHARMACEUTICALS INC shareholders